Skip to main content
Signal8

CONLEY SHERYL L

SEC insider (Form 3/4/5 filer). CIK 0001238659. Director at Anika Therapeutics, Inc. (ANIK) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in BEDFORD, MA.

Companies CONLEY SHERYL L has filed insider reports for

  • Anika Therapeutics, Inc. (ANIK): Director
  • Neuronetics, Inc. (STIM): Director
CONLEY SHERYL L profile photo

CONLEY SHERYL L

CIK: 0001238659

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Anika Therapeutics, Inc. logo
ANIK

Anika Therapeutics, Inc.

Director
Neuronetics, Inc. logo
STIM

Neuronetics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Jun 18, 2026
    Award
    Direct
    10.4K shares-
  • Neuronetics, Inc. logo
    STIM

    Neuronetics, Inc.

    May 28, 2026
    Award
    Direct
    30K shares-
  • Neuronetics, Inc. logo
    STIM

    Neuronetics, Inc.

    Oct 20, 2025
    Award
    Direct
    7.3K shares-
  • Anika Therapeutics, Inc. logo
    ANIK

    Anika Therapeutics, Inc.

    Jun 20, 2025
    Award
    Direct
    14.2K shares-
  • Neuronetics, Inc. logo
    STIM

    Neuronetics, Inc.

    May 22, 2025
    Award
    Direct
    30K shares-
  • Neuronetics, Inc. logo
    STIM

    Neuronetics, Inc.

    Feb 7, 2025
    Other
    Direct
    44.4K shares at avg. $2.25$100K

1-6 of 6